title: Recent advances in carbohydrate-based vaccines.
abstract: Vaccinations provide an efficient and cost-effective way to combat devastating human diseases. Besides pathogenic protein markers, cell surface carbohydrates from biological sources are widely used as vaccines. Recently, synthetic immunogenic carbohydrate-protein conjugates have been advanced to vaccine candidates. Progress in the chemical synthesis of oligosaccharides and conjugation methods stimulated the development of novel carbohydrate-based vaccine candidates.
authors: Max-Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany.
authors: Marie-Lyn
authors: ML
authors: Hecht
authors: Pierre
authors: P
authors: Stallforth
authors: Daniel Varón
authors: DV
authors: Silva
authors: Alexander
authors: A
authors: Adibekian
authors: Peter H
authors: PH
authors: Seeberger
mesh_terms: D016915:AIDS Vaccines; D000818:Animals; D002241:Carbohydrates / Q000737:chemistry / Q000276:immunology*; D006001:Glycoconjugates / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D014612:Vaccines / Q000737:chemistry / Q000276:immunology*
chemical_list: D016915:AIDS Vaccines; D002241:Carbohydrates; D006001:Glycoconjugates; D014612:Vaccines